— Know what they know.
Not Investment Advice

BIOA NASDAQ

BioAge Labs, Inc.
1W: -10.6% 1M: -8.8% 3M: -18.4% YTD: +30.5% 1Y: +307.3%
$16.61
-0.13 (-0.78%)
 
Weekly Expected Move ±9.6%
$14 $16 $18 $19 $21
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 40 · $625.4M mcap · 24M float · 1.98% daily turnover · Short 51% of daily vol

Balance Sheet Trends

Total Assets
$295M -17.7% ▼
3Y CAGR: +118.1%
Total Liabilities
$23M -34.9% ▼
3Y CAGR: -45.5%
Shareholders Equity
$272M -15.8% ▼
Cash & Investments
$281M -20.7% ▼
3Y CAGR: +116.6%
Total Debt
$6M -36.1% ▼
3Y CAGR: +31.1%
Net Debt
-$183M +47.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$28M$22M$354M$189M
Short-Term Investments$0$0$0$92M
Cash & ST Investments$28M$22M$354M$281M
Net Receivables$0$0$0$769K
Inventory$0$0$0$0
Other Current Assets$386K$4M$3M$5M
Total Current Assets$28M$25M$357M$287M
Property, Plant & Equip.$374K$518K$791K$4M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$100K$100K$100K
Other Non-Current Assets$25K$0$240K$4M
Total Non-Current Assets$399K$618K$1M$8M
Total Assets$28M$26M$358M$295M
— Liabilities —
Accounts Payable$2M$2M$2M$3M
Short-Term Debt$167K$45M$6M$3M
Deferred Revenue$0$3M$8M$6M
Other Current Liabilities$24K$1M$417K$8M
Total Current Liabilities$6M$58M$28M$20M
Long-Term Debt$2M$8M$3M$2M
Other Non-Current Liab.$133M$133M$156K$370K
Total Non-Current Liabilities$135M$141M$7M$3M
Total Liabilities$141M$199M$35M$23M
— Equity —
Common Stock$0$0$0$0
Retained Earnings-$118M-$182M-$253M-$333M
Accumulated OCI$167K$164K$245K$278K
Total Stockholders Equity-$113M-$173M$323M$272M
Total Liabilities & Equity$28M$26M$358M$295M
— Key Metrics —
Total Debt$2M$53M$9M$6M
Net Debt-$25M$32M-$346M-$183M
Total Investments$0$100K$100K$92M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms